BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30287408)

  • 1. Combined use of biocompatible nanoemulsions and solid microneedles to improve transport of a model NSAID across the skin: In vitro and in vivo studies.
    Ilić T; Savić S; Batinić B; Marković B; Schmidberger M; Lunter D; Savić M; Savić S
    Eur J Pharm Sci; 2018 Dec; 125():110-119. PubMed ID: 30287408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatible Nanoemulsions for Improved Aceclofenac Skin Delivery: Formulation Approach Using Combined Mixture-Process Experimental Design.
    Isailović T; Ðorđević S; Marković B; Ranđelović D; Cekić N; Lukić M; Pantelić I; Daniels R; Savić S
    J Pharm Sci; 2016 Jan; 105(1):308-23. PubMed ID: 26539935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatible microemulsions of a model NSAID for skin delivery: A decisive role of surfactants in skin penetration/irritation profiles and pharmacokinetic performance.
    Todosijević MN; Savić MM; Batinić BB; Marković BD; Gašperlin M; Ranđelović DV; Lukić MŽ; Savić SD
    Int J Pharm; 2015 Dec; 496(2):931-41. PubMed ID: 26497615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
    Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
    AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
    Dasgupta S; Ghosh SK; Ray S; Mazumder B
    Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation.
    Shakeel F; Baboota S; Ahuja A; All J; Shafiq S
    Pharmazie; 2008 Aug; 63(8):580-4. PubMed ID: 18771006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation.
    Dasgupta S; Dey S; Choudhury S; Mazumder B
    Expert Opin Drug Deliv; 2013 Apr; 10(4):411-20. PubMed ID: 23316798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of sucrose stearate-based nanoemulsions and optimisation through γ-cyclodextrin.
    Klang V; Matsko N; Raupach K; El-Hagin N; Valenta C
    Eur J Pharm Biopharm; 2011 Sep; 79(1):58-67. PubMed ID: 21277976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
    Raju YP; Haritha K; Satyanarayana RP; Vandana KR; Bindu DT; Vinesha V; Chowdary VH
    Curr Drug Deliv; 2015; 12(6):703-8. PubMed ID: 25751659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.
    Bachhav YG; Heinrich A; Kalia YN
    Eur J Pharm Biopharm; 2011 Aug; 78(3):408-14. PubMed ID: 21397689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of microemulsion systems for transdermal delivery of aceclofenac.
    Lee J; Lee Y; Kim J; Yoon M; Choi YW
    Arch Pharm Res; 2005 Sep; 28(9):1097-102. PubMed ID: 16212244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
    Rhee YS; Nguyen T; Park ES; Chi SC
    Arch Pharm Res; 2013 May; 36(5):602-7. PubMed ID: 23475315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of aceclofenac microemulsion for transdermal delivery system.
    Yang JH; Kim YI; Kim KM
    Arch Pharm Res; 2002 Aug; 25(4):534-40. PubMed ID: 12214868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances.
    Đorđević SM; Santrač A; Cekić ND; Marković BD; Divović B; Ilić TM; Savić MM; Savić SD
    Int J Pharm; 2017 Nov; 533(2):421-430. PubMed ID: 28552767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
    Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
    Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical delivery of aceclofenac from lecithin organogels: preformulation study.
    Shaikh IM; Jadhav KR; Gide PS; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2006 Oct; 3(4):417-27. PubMed ID: 17076644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
    Klang V; Matsko N; Zimmermann AM; Vojnikovic E; Valenta C
    Int J Pharm; 2010 Jun; 393(1-2):152-60. PubMed ID: 20434531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
    Sivaraman A; Banga AK
    Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
    Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
    Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
    J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.